|Application ||WB, IHC-P, E|
|Calculated MW||30392 Da|
|Dilution||ELISA (1:32000), IHC-P (5 µg/ml), WB (0.03 - 0.1 µg/ml)|
|Other Names||TNFRSF14, CD270, CD270 antigen, CD40-like protein, Herpesvirus entry mediator, Herpesvirus entry mediator A, HVEM, LIGHTR, Herpes virus entry mediator A, TR2, ATAR, HVEA|
|Reconstitution & Storage||Immunoaffinity purified|
|Precautions||Anti-TNFRSF14 / CD270 / HVEM Antibody (aa240-251) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Receptor for BTLA. Receptor for TNFSF14/LIGHT and homotrimeric TNFSF1/lymphotoxin-alpha. Involved in lymphocyte activation. Plays an important role in HSV pathogenesis because it enhanced the entry of several wild-type HSV strains of both serotypes into CHO cells, and mediated HSV entry into activated human T-cells.|
|Cellular Location||Membrane; Single-pass type I membrane protein|
|Tissue Location||Widely expressed, with the highest expression in lung, spleen and thymus|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.